Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mainz Biomed NV MYNZ

Healthcare Biotechnology
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of... see more

Recent & Breaking News (NDAQ:MYNZ)

Mainz Biomed to Exhibit ColoAlert at MEDICA 2021, the World's Largest Medical Trade Fair

GlobeNewswire November 15, 2021

Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board

GlobeNewswire November 11, 2021

Mainz Biomed Announces Exercise of Over-Allotment Option

GlobeNewswire November 8, 2021

Mainz Biomed Commences Trading on Nasdaq Under Ticker Symbol 'MYNZ'

GlobeNewswire November 8, 2021

MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market

GlobeNewswire November 5, 2021

MYNZ Shares Have Commenced Trading on the Nasdaq Capital Market

GlobeNewswire November 5, 2021